Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Syndromic disease · Developmental anomaly of metabolic origin · Leukodystrophy · Peroxisomal disease
CADDS
CADDS is a rare, genetic, neurometabolic disease characterized by severe intrauterine growth retardation, failure to thrive, profound neonatal hypotonia, severe global development delay, elevated very long chain fatty acids in plasma, and neonatal cholestasis leading to hepatic failure and death. Other features include ocular abnormalities (e.g. blindness and cataracts), sensorineural deafness, seizures, and abnormal brain morphology (notably delayed CNS myelination and ventriculomegaly).
This condition has no sub-types.